🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHeart failure hospitalization reduction on semaglutide — real-world data Page 4

Heart failure hospitalization reduction on semaglutide — real-world data

Dr.CardioMD Sat, May 23, 2026 at 6:53 AM 18 replies 644 viewsPage 4 of 4
SandraNC_45
Member
312
1,345
Sep 2024
Charlotte, NC
May 25, 2026 at 1:55 PM#16
Dr.RenalNash said:
I'm 67 years old and want to share my perspective on cardiovascular risk as an older member of this community.

Adding a me-too, because a thread of one person's experience is not much use.

30 5FranDenver, Dr.BariatricHTX, LindaRN_retired and 27 others
Reply Quote Save Share Report
MounjBrad
Member
278
890
Oct 2024
Kentucky
May 25, 2026 at 5:18 PM#17
stefan_berlin said:
Dr.CardioMD said: ...we don't know the long-term effects of cardiovascular risk...

Senior perspective on cardiovascular risk: I'm 64 years old and started this journey skeptically. My cardiologist recommended it after years of failed interventions.

14 months later: down 37 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

29 4ben_calgary, patPC_UT, Dr.DermMIA and 26 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
May 25, 2026 at 8:41 PM#18

One concrete data point for the thread. Worth knowing that the injection site changes very little. Abdomen, thigh and upper arm are bioequivalent for semaglutide, so a site change is not a plausible explanation for a bad week.

Last edited: May 26, 2026 at 12:41 AM
28 3FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 25 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
mona_PHX
Member
189
890
Dec 2024
Phoenix, AZ
May 26, 2026 at 12:04 AM#19

One thing that is still open after stefan_berlin’s answer:

How much of the between-person variation is pharmacokinetic and how much is just adherence measured badly?

Last edited: May 26, 2026 at 3:04 AM
27 2CryptoCarl, MariaRD, AussieAnna and 24 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 26, 2026 at 3:27 AM#20

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Carry on.

5 5PurityPaulOR, MaxMetOK, MounjBrad and 2 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register